NASDAQ:ADGM - Nasdaq - US00534B1008 - Common Stock - Currency: USD
1.11
+0.11 (+11%)
The current stock price of ADGM is 1.11 USD. In the past month the price increased by 40.51%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.16 | 225.18B | ||
ISRG | INTUITIVE SURGICAL INC | 63.87 | 174.81B | ||
BSX | BOSTON SCIENTIFIC CORP | 36.64 | 146.31B | ||
SYK | STRYKER CORP | 29.3 | 136.31B | ||
MDT | MEDTRONIC PLC | 15.68 | 107.41B | ||
BDX | BECTON DICKINSON AND CO | 14.54 | 58.09B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.1 | 41.42B | ||
IDXX | IDEXX LABORATORIES INC | 37.92 | 34.57B | ||
RMD | RESMED INC | 23.62 | 31.49B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 14.45 | 29.71B | ||
DXCM | DEXCOM INC | 40.52 | 26.22B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.48 | 22.99B |
Adagio Medical Holdings, Inc. is a medical device company, which engages in the development and placing on the EU market of innovative ablation technologies for the treatment of cardiac arrhythmias. The company is headquartered in Laguna Hills, California. The company went IPO on 2021-02-26. The company is focused on developing proprietary Ultra-Low Temperature Cryoablation technology that creates contiguous, transmural lesions to treat cardiac arrhythmias, with an emphasis on ventricular tachycardia. The company is developing and placing on the European Union (EU) market ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio consists of three product families: iCLAS atrial ULTC catheter and accessories, vCLAS ventricular ULTC catheter, and Cryopulse atrial PFCA catheter and accessories. All of these catheters share the same ULTC cryoablation console. The iCLAS system is CE-marked with the indication for treatment of paroxysmal atrial fibrillation, persistent atrial fibrillation and atrial flutter. The vCLAS ventricular catheter has been specifically designed for the treatment of ventricular arrhythmia.
ADAGIO MEDICAL HOLDINGS INC
26051 Merit Circle, Suite 102
Laguna Hills CALIFORNIA US
Employees: 0
Company Website: http://www.perceptivelife.com/arya4/
Phone: 12122842300
The current stock price of ADGM is 1.11 USD. The price increased by 11% in the last trading session.
The exchange symbol of ADAGIO MEDICAL HOLDINGS INC is ADGM and it is listed on the Nasdaq exchange.
ADGM stock is listed on the Nasdaq exchange.
ADAGIO MEDICAL HOLDINGS INC (ADGM) has a market capitalization of 17.07M USD. This makes ADGM a Nano Cap stock.
ADAGIO MEDICAL HOLDINGS INC (ADGM) currently has 0 employees.
ADAGIO MEDICAL HOLDINGS INC (ADGM) has a support level at 0.75 and a resistance level at 1.71. Check the full technical report for a detailed analysis of ADGM support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ADGM does not pay a dividend.
ADAGIO MEDICAL HOLDINGS INC (ADGM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.19).
The outstanding short interest for ADAGIO MEDICAL HOLDINGS INC (ADGM) is 2.25% of its float. Check the ownership tab for more information on the ADGM short interest.
ChartMill assigns a technical rating of 5 / 10 to ADGM.
ChartMill assigns a fundamental rating of 1 / 10 to ADGM. Both the profitability and financial health of ADGM have multiple concerns.
Over the last trailing twelve months ADGM reported a non-GAAP Earnings per Share(EPS) of -0.19. The EPS decreased by -307% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -6.83% | ||
ROE | -11.32% | ||
Debt/Equity | 0.14 |